GET DAILY SIGNALSWhy Is The Pennant Group (PNTG) Stock Down -7.28% Today?
Key Takeaways
- PNTG shares fell roughly 7.28% to about $37.09, extending a sharp two-day slide from the $44.04 close recorded on November 4.
- The decline is a continuation of the post-earnings selloff triggered by margin pressure in the company's third-quarter 2026 results, reported after the market close on November 4.
- Higher-than-expected employee benefits costs and integration challenges in two senior living markets weighed on profitability despite a 32% jump in revenue.
- Fresh analyst price-target increases from RBC Capital and Oppenheimer did not halt the selling, underscoring lingering investor concern about near-term margins.
- Full-year guidance was reaffirmed, leaving traders focused on whether occupancy and cost trends stabilize in the fourth quarter.
- For additional context on this stock, explore its Price Targets, Earnings, and Forecast pages.
- Discover which AI strategies are outperforming under current conditions by exploring Trending AI Robots.
Opening Summary
The Pennant Group, Inc. (PNTG), an Eagle, Idaho-based provider of home health, hospice, and senior living services, saw its shares fall about 7.28% to roughly $37.09 on November 6, 2026, versus a prior closing price of $40.00. The move extends a post-earnings pullback that began after the company reported third-quarter results on November 4. Markets pointed to margin pressure from elevated employee benefits costs and softer senior living performance as the immediate drivers, even as top-line growth remained robust.
Earnings Results: Margin Pressure Overshadows Strong Revenue
The principal catalyst behind the decline traces back to third-quarter 2026 results. Revenue climbed 32% year over year to $302.3 million, slightly ahead of the roughly $299.3 million consensus estimate, while adjusted earnings per share came in at $0.35 and adjusted EBITDA rose 42.4% to $24.7 million. Yet investors focused on the quality of that growth rather than its headline strength.
Management reported higher-than-anticipated employee benefits costs that reduced margins by approximately 50 basis points of revenue, an impact the company said is likely to persist into the fourth quarter. At the same time, the senior living segment faced integration challenges concentrated in two markets where rapid acquisition activity temporarily outpaced leadership capacity. Same-store senior living occupancy declined 60 basis points to 81.2%, and segment adjusted EBITDA growth slowed sharply, compressing margins.
Although full-year guidance was reaffirmed, the shift in tone—from pointing toward the upper end of the range to describing results as simply on pace—gave investors reason to reassess near-term profitability. The shares, which had climbed near a 52-week high of $44.24 ahead of the report, have since retraced materially.
Analyst Reactions Fail to Halt the Slide
Wall Street's response underscored the mixed nature of the quarter. RBC Capital raised its price target on PNTG to $48 from $44 and maintained an Outperform rating, characterizing the occupancy pressure as isolated and temporary while framing the post-earnings weakness as a buying opportunity. Oppenheimer similarly lifted its target to $50 from $47 and kept an Outperform rating. Despite these supportive calls and a consensus rating of Strong Buy, sellers remained in control, suggesting that concerns about cost inflation and integration execution outweighed the more constructive analyst commentary in the near term.
Market Context and Trading Activity
Trading activity has been notably heavy during the two-day decline. Volume on November 5 surged to roughly 1.7 million shares, well above the stock's typical average daily volume near 320,000 to 470,000, reflecting broad participation in the move. The selloff has also taken the shares below both their 50-day moving average near $40 and their recent consolidation range, breaking through short-term support levels as the stock trades well below its 52-week high.
The move reflects company-specific factors more than broad market weakness, as investors continue to differentiate within the healthcare-services and senior living sector. The pullback comes despite strong multi-year fundamentals for the company, including accelerating admissions across home health and hospice operations, leaving the recent decline tied primarily to margin and integration concerns.
What Comes Next for PNTG
Traders will be watching whether senior living occupancy and operating performance stabilize in the two markets flagged by management, and whether elevated benefits costs moderate as executives suggested they have built into fourth-quarter projections. The completion of the electronic medical records transition in the Southeast at the end of October removes one source of operational disruption, and the company has reaffirmed its full-year adjusted EPS guidance range of $1.34 to $1.41.
Key risks include further integration lumpiness across recently acquired communities, persistent wage and benefits inflation, and the broader regulatory environment for home health reimbursement. Should fourth-quarter results confirm that the margin pressures are transient, the shares could find support; continued cost escalation or occupancy weakness would likely extend the decline. Upcoming earnings, occupancy trends, and analyst estimate revisions remain the primary watch items.
Trending AI Robots
Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots that are currently among the strongest performers in prevailing market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with strategies that vary by approach, timeframe, performance metrics, and traded symbols. Only the top-performing robots under current market dynamics are featured in this section, making it a useful starting point for traders seeking data-driven strategies. Explore the page to see which AI approaches are leading today.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
PNTG in downward trend: price dove below 50-day moving average on November 05, 2026
PNTG moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend. In 34 of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 79%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PNTG as a result. In 61 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 67%.
The Moving Average Convergence Divergence Histogram (MACD) for PNTG turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In 32 of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at 60%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PNTG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 63 cases where PNTG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
Following a +8.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where PNTG advanced for three days, in 244 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
PNTG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 181 of 236 cases where PNTG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 29 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. PNTG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 54 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.536) is normal, around the industry mean (204.220). P/E Ratio (38.681) is within average values for comparable stocks, (21.249). Projected Growth (PEG Ratio) (2.017) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.154) among similar stocks. P/S Ratio (1.373) is also within normal values, averaging (2.688).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company, which engages in the provision of healthcare services
Industry HospitalNursingManagement
Advertisement